Print

Easton Pharmaceuticals (OP: EAPH) Provides Update on Its Medical Marijuana Initiatives  
8/23/2013 9:33:41 AM

free biotech news Get the latest biotech news where 

you want it. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Easton Pharmaceuticals, Inc. (OTC:EAPH), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announced updates to its Canadian and United States Medical Marijuana initiatives. Easton, in its quest to enter into new business segments and products, has entered into discussions with 2 private independent companies in Canada for a proposed joint venture or partnership where it would share in any revenues generated in the medical Marijuana industry. Both of the companies currently possess growers licenses within various Provinces in Canada with one of them having affiliations within a clinical marijuana friendly state. Terms being discussed are issuing shares of Easton stock, cash payments to be made by Easton or a combination of both. The companies are considered well respected and due to the fact they currently maintain growers licenses, it is believed they would have a better chance in obtaining licenses under the proposed new medical marijuana rules set to launch in March of 2014.

Help employers find you! Check out all the jobs and post your resume.

//-->